DE69433464D1 - Mit zellen beschichtete künstliche nieren betreffende vorrichtungen zum in vivo oder ex vivo gebrauch - Google Patents

Mit zellen beschichtete künstliche nieren betreffende vorrichtungen zum in vivo oder ex vivo gebrauch

Info

Publication number
DE69433464D1
DE69433464D1 DE69433464T DE69433464T DE69433464D1 DE 69433464 D1 DE69433464 D1 DE 69433464D1 DE 69433464 T DE69433464 T DE 69433464T DE 69433464 T DE69433464 T DE 69433464T DE 69433464 D1 DE69433464 D1 DE 69433464D1
Authority
DE
Germany
Prior art keywords
vivo
bioreactor
kidney
hollow fiber
related devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433464T
Other languages
English (en)
Other versions
DE69433464T2 (de
Inventor
H Humes
A Cieslinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of DE69433464D1 publication Critical patent/DE69433464D1/de
Application granted granted Critical
Publication of DE69433464T2 publication Critical patent/DE69433464T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0687—Renal stem cells; Renal progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/06—Tubular
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/16—Hollow fibers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/25—Urinary tract cells, renal cells
    • C12N2502/256—Renal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
DE69433464T 1993-10-08 1994-10-11 Mit zellen beschichtete künstliche nieren betreffende vorrichtungen zum in vivo oder ex vivo gebrauch Expired - Lifetime DE69433464T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US133436 1993-10-08
US08/133,436 US5549674A (en) 1992-03-02 1993-10-08 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
PCT/US1994/011384 WO1995011048A2 (en) 1993-10-08 1994-10-11 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)

Publications (2)

Publication Number Publication Date
DE69433464D1 true DE69433464D1 (de) 2004-02-05
DE69433464T2 DE69433464T2 (de) 2004-11-11

Family

ID=22458619

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433464T Expired - Lifetime DE69433464T2 (de) 1993-10-08 1994-10-11 Mit zellen beschichtete künstliche nieren betreffende vorrichtungen zum in vivo oder ex vivo gebrauch

Country Status (8)

Country Link
US (2) US5549674A (de)
EP (1) EP0746343B1 (de)
JP (2) JP3614853B2 (de)
AT (1) ATE257018T1 (de)
AU (1) AU692191B2 (de)
CA (2) CA2173594C (de)
DE (1) DE69433464T2 (de)
WO (1) WO1995011048A2 (de)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410320B1 (en) 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
JPH09512184A (ja) * 1994-04-29 1997-12-09 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 内皮下細胞外基質上の内皮を利用する改善された血液接触表面
US6152141A (en) * 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
US6372495B1 (en) * 1995-10-06 2002-04-16 Seed Capital Investments-2 (Sci-2) B.V. Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen
ATE260076T1 (de) * 1996-09-05 2004-03-15 Childrens Medical Center Nierenprothese
US6673339B1 (en) 1996-09-05 2004-01-06 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
US6150164A (en) * 1996-09-30 2000-11-21 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5902336A (en) * 1996-10-15 1999-05-11 Mirimedical, Inc. Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure
ATE248615T1 (de) * 1997-10-31 2003-09-15 Childrens Medical Center Blasenrekonstruktion
EP1042019B1 (de) * 1997-10-31 2006-06-07 Children's Medical Center Corporation Penis-rekonstruktion
WO2000061630A1 (en) * 1999-04-08 2000-10-19 President And Fellows Of Harvard College Induction of kidney tubule formation
CA2369576C (en) * 1999-04-23 2005-07-05 William Frederick Weitzel Extracorporeal circuit and related methods
AU2004201641B2 (en) * 1999-04-30 2007-04-19 The Charles Stark Draper Laboratory, Inc. Fabrication of Vascularized Tissue Using Microfabricated Two-Dimensional Molds
EP1187909B1 (de) * 1999-04-30 2005-02-02 Massachusetts General Hospital Herstellung von dreidimensionalem vaskularisierten gewebe mittels der verwendung von zweidimensionalen mikrohergestellten formen
US7759113B2 (en) * 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
US20040167634A1 (en) * 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
JP3229599B2 (ja) * 1999-06-01 2001-11-19 ホスパル株式会社 血液浄化装置とそれを使用した人工腎臓
NZ516777A (en) * 1999-08-10 2004-12-24 Ml Lab Plc Method for delivery of therapeutic agents, particularly nucleic acids, using a solution of dextrin
DE19943205C1 (de) * 1999-09-10 2000-11-16 Geesthacht Gkss Forschung Verfahren zur Erzeugung, zum Transport und zur Eliminierung von biochemischen Stoffen mittels aktiver biologischer Zellen
US6479064B1 (en) 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
JP4813734B2 (ja) * 2000-03-31 2011-11-09 ザ ジェネラル ホスピタル コーポレイション 毛の成長を調節する方法
US7776021B2 (en) * 2000-04-28 2010-08-17 The Charles Stark Draper Laboratory Micromachined bilayer unit for filtration of small molecules
CN101172171B (zh) * 2000-10-12 2012-12-12 肾脏治疗公司 在体液体外处理中用于体液流动控制的装置和方法
US6538010B1 (en) * 2000-11-08 2003-03-25 Research Triangle Institute Compounds and methods for promoting smoking cessation
US6627164B1 (en) * 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
US7033498B2 (en) * 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
WO2002055136A2 (en) * 2000-12-01 2002-07-18 Nephros Therapeutics Inc Intrasvascular drug delivery device and use therefor
US7476210B2 (en) * 2001-01-04 2009-01-13 Transvivo Inc. Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant
US6659973B2 (en) * 2001-01-04 2003-12-09 Transvivo, Inc. Apparatus and method for in-vivo plasmapheresis using periodic backflush
US6582955B2 (en) * 2001-05-11 2003-06-24 Spectrum Laboratories, Inc. Bioreactor with application as blood therapy device
EP1388327B1 (de) * 2001-05-17 2012-02-22 Kaneka Corporation Künstliche niere mit proteinmetabolisierungsfunktion und verfahren zu ihrer herstellung
US6653131B2 (en) 2001-08-30 2003-11-25 The Regents Of The University Of Michigan Method of treating systemic inflammatory response syndrome
US7332330B2 (en) * 2001-09-11 2008-02-19 Renamed Biologics, Inc. Device for maintaining vascularization near an implant
BR0214217A (pt) * 2001-11-16 2004-09-21 Childrens Medical Center Aumento de função de órgão
US6878283B2 (en) * 2001-11-28 2005-04-12 Renal Solutions, Inc. Filter cartridge assemblies and methods for filtering fluids
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7771716B2 (en) * 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
EP1921133B1 (de) 2001-12-07 2015-05-20 Cytori Therapeutics, Inc. System zur Behandlung von Zellen aus Lipoaspirat
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US8404229B2 (en) * 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050095228A1 (en) * 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7442546B2 (en) * 2002-03-15 2008-10-28 The Regents Of The University Of Michigan Method of modulating inflammatory response
WO2004024300A1 (en) * 2002-09-11 2004-03-25 The Regents Of The University Of Michigan Ultrafiltration membrane, device, bioartificial organ and methods
EP1589814B1 (de) * 2003-01-16 2009-08-12 The General Hospital Corporation Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
US7960166B2 (en) 2003-05-21 2011-06-14 The General Hospital Corporation Microfabricated compositions and processes for engineering tissues containing multiple cell types
US7998101B2 (en) * 2003-07-28 2011-08-16 Renal Solutions, Inc. Devices and methods for body fluid flow control in extracorporeal fluid treatment
AU2004269409A1 (en) * 2003-08-29 2005-03-10 Regents Of The University Of Minnesota Kidney derived stem cells and methods for their isolation, differentiation and use
EP1743022A4 (de) * 2004-02-27 2008-02-06 Gen Hospital Corp Verfahren und zusammensetzungen für haarwachstum
DE102004017476B4 (de) 2004-04-08 2009-03-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung einer Epithelzellen enthaltenden Zellzusammensetzung
WO2006014162A2 (en) * 2004-07-01 2006-02-09 Macropore Biosurgery Inc. Methods of using regenerative cells in the treatment of renal diseases and disorders
US7083653B2 (en) * 2004-08-12 2006-08-01 Charles Edward Jennings Implantable human kidney replacement unit
EP1844434A4 (de) * 2005-01-10 2013-11-13 Cytori Therapeutics Inc Einrichtungen und verfahren zum überwachen, verwalten und warten medizinischer einrichtungen
US9427496B2 (en) 2005-02-18 2016-08-30 Drexel University Method for creating an internal transport system within tissue scaffolds using computer-aided tissue engineering
US7874998B2 (en) * 2005-11-04 2011-01-25 The Regents Of The University Of Michigan Filtration devices and related methods thereof
US8764697B2 (en) * 2006-02-01 2014-07-01 Agathos Holdings Llc Systems and methods for an advanced medical device
US8096967B2 (en) * 2006-02-02 2012-01-17 Milan Radojicic Tissue engineered cerebrospinal fluid shunt
WO2007092735A2 (en) 2006-02-02 2007-08-16 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
US8715221B2 (en) * 2006-03-08 2014-05-06 Fresenius Medical Care Holdings, Inc. Wearable kidney
US8012118B2 (en) * 2006-03-08 2011-09-06 Fresenius Medical Care Holdings, Inc. Artificial kidney dialysis system
US20080090765A1 (en) * 2006-05-25 2008-04-17 The Trustees Of Columbia University In The City Of New York Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
US9770180B2 (en) * 2006-08-17 2017-09-26 Milan Radojicic System and method for monitoring and delivering therapeutics to the spinal cord
US10478555B2 (en) 2006-08-17 2019-11-19 Milan Radojicic Systems and methods for lumbar cerebrospinal fluid access and treatment
US20080045611A1 (en) * 2006-08-17 2008-02-21 Milan Radojicic Methods for the therapeutic use of a carbonic anhydrase inhibitor for reducing spinal cord edema
DE102006042732B3 (de) * 2006-09-12 2008-04-10 Gerlach, Jörg, Dr.med. Künstliches arterio-venöses permeables Hohlfaserkapillarsystem
DK2578081T3 (en) 2006-10-11 2016-06-27 Massachusetts Gen Hospital Compositions, methods and devices for the treatment of liver disease
JP4672632B2 (ja) * 2006-10-17 2011-04-20 学校法人東海大学 バイオ人工糸球体
WO2008047760A1 (fr) * 2006-10-17 2008-04-24 Tokai University Educational System Tubule rénal bioartificiel
EP2125171A4 (de) 2007-01-10 2012-05-16 Univ Michigan Ultrafiltriermembran, vorrichtung, bioartifizielles organ und entsprechende verfahren
CA2678893C (en) * 2007-03-05 2015-12-29 Caridianbct, Inc. Methods to control cell movement in hollow fiber bioreactors
CN101827933B (zh) * 2007-06-08 2014-01-29 韦克福里斯特大学健康科学院 治疗肾功能衰竭的选择性细胞疗法
WO2010071692A2 (en) 2008-06-18 2010-06-24 Innovative Biotherapies, Inc. Methods for enhanced propagation of cells
US9463276B2 (en) 2008-08-16 2016-10-11 Milan Radojicic Systems and methods for a computational medical device in dynamic body systems
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
EP2168668A1 (de) 2008-09-25 2010-03-31 Gambro Lundia AB Membran für Zellexpansion
EP2177603A1 (de) * 2008-09-25 2010-04-21 Gambro Lundia AB Vorrichtung für Nierenzellexpansion
EP2168666A1 (de) 2008-09-25 2010-03-31 Gambro Lundia AB Bestrahlte Membran für Zellexpansion
EP2314672B1 (de) 2008-09-25 2015-04-15 Gambro Lundia AB Hybride biologische künstliche Niere
WO2010062716A2 (en) * 2008-11-03 2010-06-03 Fresenius Medical Care Holdings, Inc. Portable peritoneal dialysis system
AU2009312342B2 (en) * 2008-11-06 2014-01-23 Xerem Medical Ltd. Blood filtering device and method
EP3388509A1 (de) 2008-11-12 2018-10-17 inRegen Isolierte nierenzellen und verwendungen davon
WO2010057015A1 (en) * 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
WO2010057013A1 (en) * 2008-11-14 2010-05-20 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
US20110236874A1 (en) * 2008-12-02 2011-09-29 Daniele Zink Method for formation of renal tubules
AU2010242780B2 (en) 2009-05-01 2016-04-21 Puregraft Llc Systems, methods and compositions for optimizing tissue and cell enriched grafts
EP2566951B1 (de) 2010-05-05 2020-03-04 Terumo BCT, Inc. Verfahren zur neuaussaat von in einem hohlfaser-bioreaktorsystem gezüchteten adhärenten zellen
KR102428776B1 (ko) 2010-05-12 2022-08-04 인리젠 생물활성 신장 세포
EP2412798A1 (de) * 2010-07-27 2012-02-01 Gambro Lundia AB Biomimetische Membran zur Kultivierung von Zellen
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
SG190002A1 (en) * 2010-10-25 2013-06-28 Agency Science Tech & Res Tubular fiber membrane with nanoporous skin
CA2817206C (en) 2010-11-10 2020-03-10 Tengion, Inc. Injectable formulations for organ augmentation
CA2839435C (en) * 2011-06-15 2021-05-11 The Charles Stark Draper Laboratory, Inc. Systems, methods, and devices relating to a biomimetic cellularized nephron unit
US9649427B2 (en) 2011-12-28 2017-05-16 Xerem Medical Ltd. System and method for blood filtering and/or treatment
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN105457118B (zh) * 2015-12-17 2018-01-02 珠海健帆生物科技股份有限公司 血液净化装置及系统
CN105733944A (zh) * 2016-05-04 2016-07-06 浙江大学 六孔板肝细胞中空纤维反应器的构建方法
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
EP3509653A4 (de) * 2016-09-06 2020-04-29 President and Fellows of Harvard College Lebende vorrichtung zum ersetzen von organen oder spezifischen organfunktionen, verfahren und verwendungen davon
US11052230B2 (en) * 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US11702634B2 (en) 2017-03-31 2023-07-18 Terumo Bct, Inc. Expanding cells in a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3778872A4 (de) * 2018-04-13 2022-01-05 Nikkiso Co., Ltd. Zellkulturverfahren, verfahren zur herstellung eines zellträgerkomplexes, kultivierte zelle und zellträgerkomplex
WO2023210765A1 (ja) * 2022-04-28 2023-11-02 株式会社クラレ 免疫隔離デバイス

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734851A (en) * 1969-12-29 1973-05-22 K Matsumura Method and device for purifying blood
CA1027304A (en) * 1973-06-06 1978-03-07 Theodore E. Spielberg Artificial gland structure
US4242460A (en) * 1978-12-26 1980-12-30 Chick William L Cell culture device
EP0058275A1 (de) * 1981-02-17 1982-08-25 SENKO MEDICAL INSTRUMENT Mfg Co., LTD Künstliche Niere aus Hohlfasern
US4354933A (en) * 1981-02-23 1982-10-19 Lester James P Implantable artificial kidney
JPS61115569A (ja) * 1984-11-09 1986-06-03 テルモ株式会社 一過性白血球減少症軽減用人工腎臓およびその製造方法
US5035708A (en) * 1985-06-06 1991-07-30 Thomas Jefferson University Endothelial cell procurement and deposition kit
IL78950A (en) * 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
JP2739758B2 (ja) * 1987-02-24 1998-04-15 ヴィレス，ジョセフ・エム 形質転換細胞株を用いる肝臓補助装置
WO1989001967A1 (en) * 1987-09-03 1989-03-09 Brown University Research Foundation Blood purification with cultured renal cells
JP2835629B2 (ja) * 1989-05-18 1998-12-14 ザ リージェンツ オブ ザ ユニヴァーシティ オブ ミネソタ バイオリアクター装置
WO1991000119A1 (en) * 1989-06-30 1991-01-10 Baxter International Inc. Implantable device
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
WO1992007615A1 (en) * 1990-10-29 1992-05-14 Regents Of The University Of Minnesota A bioartificial liver
US5429938A (en) * 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules

Also Published As

Publication number Publication date
US5549674A (en) 1996-08-27
EP0746343A1 (de) 1996-12-11
US5686289A (en) 1997-11-11
WO1995011048A3 (en) 1995-06-22
JP2004267795A (ja) 2004-09-30
JPH09503941A (ja) 1997-04-22
EP0746343A4 (de) 1997-12-03
JP3614853B2 (ja) 2005-01-26
CA2173594A1 (en) 1995-04-27
AU7970194A (en) 1995-05-08
CA2173594C (en) 2004-09-07
JP3795900B2 (ja) 2006-07-12
WO1995011048A2 (en) 1995-04-27
CA2710965A1 (en) 1995-04-27
EP0746343B1 (de) 2004-01-02
AU692191B2 (en) 1998-06-04
CA2710965C (en) 2012-10-09
ATE257018T1 (de) 2004-01-15
DE69433464T2 (de) 2004-11-11

Similar Documents

Publication Publication Date Title
DE69433464D1 (de) Mit zellen beschichtete künstliche nieren betreffende vorrichtungen zum in vivo oder ex vivo gebrauch
DE69832402D1 (de) Erzeugung von hämatopoietischen zellen aus multipotenten neuronalen stammzellen
FR2640638B1 (fr) Bioreacteur et dispositif pour la culture de cellules animales
ATE31549T1 (de) Verfahren zur zuechtung von zellkulturen.
ATE188733T1 (de) Modul zur züchtung und zur nutzung der stoffwechselleistung und/oder zum erhalt von mikroorganismen
DK494688A (da) Fremgangsmaade til opbevaring eller dyrkning af celler og poroes, uorganisk baere-membran og apparat dertil
ATE142511T1 (de) In vivo-neomorphogenese von knorpel aus zellkulturen
ATE71298T1 (de) Immunoregulation.
ATE232748T1 (de) Hemmung von gefässverengungen nach eingriffen an den gefässen
ATE231181T1 (de) Bioreaktor
UY24668A1 (es) Metodo para producir lineas de celulas inmortalizadas para crecimiento de virus
FI841358A (fi) Biologiskt aktiv sammansaettning foer rening av avfallsvatten och avluft.
BE887396A (fr) Procede de degradation biologique continue, procede de degradation biologique anaerobie et methanogene continue, et filtre biologique a utiliser
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
DE69530409T2 (de) Epithelzellen enthaltendes biomaterial und ihre verwendung als transplantat
ES2091249T3 (es) Analogos de iludina utilizables como agentes antitumorales.
DK0707634T3 (da) Stromacellelinier fra human knoglemarv og anvendelse deraf
DE3871530D1 (de) Vorrichtung zum kultivieren von ruhenden zellen in einem bioreaktor.
DE3854472D1 (de) Erhaltung der Viabilität von Mikroorganismen zur Anwendung in mikrobiellen Inokulantien.
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
FR2554124B1 (fr) Recipient pour culture " in vitro " de cellules tissus, organes vegetaux et plantes
FR2659348B1 (fr) Procede de stimulation artificielle de cellules.
DK613489D0 (da) Fremgangsmaade og apparat til forbehandling af vand, som skal filtreres i et anaerobt biologisk filter
DK1472343T3 (da) Fremgangsmåde til fremstilling af et nervetransplantat
Wang CULTIVATION OF HUMAN EPIDERMAL CELLS ON FIBRONECTIN COATED SUBSTRATE AND I'TS CLINICAL APPLICATION

Legal Events

Date Code Title Description
8364 No opposition during term of opposition